Sia Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.18 Cr
- Satisfied Charges ₹ 1.19 Cr
- Revenue Growth 45.35%
- Profit Growth 328.20%
- Ebitda 129.88%
- Net Worth 74.79%
- Total Assets -2.65%
About Sia Pharma
Sia Pharma Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 January 2008 and has a history of 17 years and one month. Its registered office is in North Delhi, Delhi, India.
The Corporate was formerly known as Sia Overseas Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.18 Cr. The company has closed loans amounting to ₹1.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harsh Wardhan and Sanju Kumari serve as directors at the Company.
Company Details
- Location
North Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900DL2008PTC172324
- Company No.
172324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Sia Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harsh Wardhan  | Managing Director | 07-Jan-2008 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanju Kumari | Director | 07-Jan-2008 | Current |
Financial Performance of Sia Pharma.
Sia Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.35% increase. The company also saw a substantial improvement in profitability, with a 328.2% increase in profit. The company's net worth Soared by an impressive increase of 74.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sia Pharma?
Unlock access to Sia Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹61.79 M
₹11.89 M
Charges Breakdown by Lending Institutions
- Others : 6.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2024 | Others | ₹1.00 Cr | Open |
| 01 Jan 2024 | Others | ₹2.50 M | Open |
| 25 Nov 2021 | Others | ₹4.76 Cr | Open |
| 25 Nov 2021 | Others | ₹1.65 M | Open |
| 28 Mar 2015 | Others | ₹1.19 Cr | Satisfied |
How Many Employees Work at Sia Pharma?
Sia Pharma has a workforce of 6 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sia Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.